UAE: Jamjoom Pharma begins bookbuilding process ahead of IPO on Saudi Exchange

Pharmaceutical company, Jamjoom Pharma, is planning to offer 30% of its share capital through an initial public offering (IPO) and listing of shares on the Main Market of the Saudi Exchange. Existing shareholder of the company, a leader in the MEA generics market, are offering 21 million shares to individual and institutional investors, subject to…

You must be a HMI Subscriber to view this content.

Subscribe Now »